KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ionis Pharmaceuticals (IONS) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Ionis Pharmaceuticals (IONS) over the last 17 years, with Q3 2025 value amounting to 0.2.

  • Ionis Pharmaceuticals' Equity Ratio fell 524.1% to 0.2 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.2, marking a year-over-year decrease of 524.1%. This contributed to the annual value of 0.2 for FY2024, which is 5146.31% up from last year.
  • According to the latest figures from Q3 2025, Ionis Pharmaceuticals' Equity Ratio is 0.2, which was down 524.1% from 0.21 recorded in Q2 2025.
  • Over the past 5 years, Ionis Pharmaceuticals' Equity Ratio peaked at 0.3 during Q1 2021, and registered a low of 0.1 during Q2 2024.
  • Over the past 5 years, Ionis Pharmaceuticals' median Equity Ratio value was 0.21 (recorded in 2025), while the average stood at 0.2.
  • Its Equity Ratio has fluctuated over the past 5 years, first plummeted by 5766.24% in 2021, then surged by 11596.89% in 2025.
  • Over the past 5 years, Ionis Pharmaceuticals' Equity Ratio (Quarter) stood at 0.3 in 2021, then dropped by 23.49% to 0.23 in 2022, then tumbled by 42.8% to 0.13 in 2023, then surged by 51.46% to 0.2 in 2024, then grew by 4.02% to 0.2 in 2025.
  • Its Equity Ratio stands at 0.2 for Q3 2025, versus 0.21 for Q2 2025 and 0.17 for Q1 2025.